Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Adage Capital Management, L.P. reported a 5.10% stake in Terns Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 12, 2026
Adage Capital Management, L.P. reported a 5.10% stake in Terns Pharmaceuticals, Inc., 5,550,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 5,550,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 5.10% | 5,550,000 |
| Robert Atchinson | 5.10% | 5,550,000 |
| Phillip Gross | 5.10% | 5,550,000 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Adage Capital Management, L.P.
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026
- Form 4 · Burroughs Amy L. · May 5, 2026